Sign Up to like & get
recommendations!
1
Published in 2020 at "Clinical and Experimental Medicine"
DOI: 10.1007/s10238-020-00628-1
Abstract: Chimeric antigen receptor (CAR) T cell therapy has come of age, offering a potentially curative option for patients who are refractory to standard anti-cancer treatments. The success of CAR T cell therapy in the setting…
read more here.
Keywords:
cell;
receptor car;
car cells;
antigen receptor ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Immunology letters"
DOI: 10.1016/j.imlet.2017.08.018
Abstract: Adoptive immunotherapy adopting chimeric antigen receptor (CAR) modified T cells has arisen attention as a hard-hitting therapy for numerous cancers. CARs are genetically engineered receptors that could stimulate tumor cytotoxicity once binding to the specific…
read more here.
Keywords:
chimeric antigen;
modified cells;
receptor car;
antigen receptor ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of adolescent and young adult oncology"
DOI: 10.1089/jayao.2021.0102
Abstract: Chimeric antigen receptor T (CAR-T) is a relatively new treatment for pediatric leukemia and has been the focused of recent advancements. CAR is manufactured to express T cells through various ways such as using retroviruses,…
read more here.
Keywords:
receptor car;
antigen receptor;
antigen;
chimeric antigen ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "British Journal of Pharmacology"
DOI: 10.1111/bph.15934
Abstract: The constitutive androstane receptor (CAR), a known xenobiotic sensor, plays an important role in drug metabolism by regulating numerous genes. The polycyclic aromatic hydrocarbon pyrene, an environmental pollutant, is a CAR activator and induces mouse…
read more here.
Keywords:
car;
receptor car;
constitutive androstane;
androstane receptor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal for Immunotherapy of Cancer"
DOI: 10.1186/s40425-018-0460-5
Abstract: Chimeric Antigen Receptor (CAR) T cell therapies – adoptive T cell therapies that have been genetically engineered for a new antigen-specificity - have displayed significant success in treating patients with hematologic malignancies, leading to three…
read more here.
Keywords:
hematologic malignancies;
receptor car;
antigen;
antigen receptor ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.5_suppl.12
Abstract: 12Background: Immune escape via downregulation of tumor associated antigens (TAAs) is an important mechanism of resistance to Chimeric Antigen Receptor (CAR) T cell therapy. Particularly in solid tumor malignancies where antigen expression could be heterogeneous,…
read more here.
Keywords:
antigen;
receptor car;
car cells;
antigen receptor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Cancer Management and Research"
DOI: 10.2147/cmar.s163225
Abstract: Abstract Axicabtagene lisoleucel (Axi-cel) is the second approved gene-alterating cancer treatment and the first in aggressive lymphoma using the “chimeric antigen receptor” (CAR) technology. T-cells from patients were transfected with CARs and reinfused after a…
read more here.
Keywords:
receptor car;
axicabtagene;
treatment;
antigen receptor ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.832765
Abstract: Chimeric antigen receptor (CAR) -T cell therapy has become one of the hot topics in tumor immunity research in recent years. Although CAR-T cell therapy is highly effective in treating hematological malignancies, there are numerous…
read more here.
Keywords:
car;
receptor car;
chimeric antigen;
antigen receptor ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2021 at "Oncology Reports"
DOI: 10.3892/or.2021.8121
Abstract: Chimeric antigen receptor (CAR) T cells directed against CD19 (CD19.CAR T cells) have yielded impressive clinical responses in the treatment of patients with lymphoid malignancies. However, resistance and/or relapse can limit treatment outcome. Risk of…
read more here.
Keywords:
receptor car;
selective inhibitors;
car cells;
antigen receptor ... See more keywords